Encorafenib

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 512 publications

Giant scalp melanoma in an immunosuppressed patient.

Giant scalp melanoma in an immunosuppressed patient.

Journal: JAAD case reports

Published: August 16, 2026

Eruptive Melanocytic Nevi Associated With Encorafenib and Cetuximab Therapy in Two Patients With BRAF V600E-Mutated Colorectal Cancer.

Eruptive Melanocytic Nevi Associated With Encorafenib and Cetuximab Therapy in Two Patients With BRAF V600E-Mutated Colorectal Cancer.

Journal: The Journal of dermatology

Published: June 25, 2026

Colorectal neuroendocrine neoplasm organoids reveal the potential therapeutic value of targeting BRAF mutations.

Colorectal neuroendocrine neoplasm organoids reveal the potential therapeutic value of targeting BRAF mutations.

Journal: Journal of the Endocrine Society

Published: June 17, 2026

A phase 2 study of encorafenib in combination with binimetinib for Chinese participants with BRAFV600E mutated metastatic non-small cell lung cancer: Results from the OCEAN II study.

A phase 2 study of encorafenib in combination with binimetinib for Chinese participants with BRAFV600E mutated metastatic non-small cell lung cancer: Results from the OCEAN II study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 17, 2026

Report from the 27th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Calgary, Alberta, 26-27 September 2025: Advances in Colon and Rectal Cancer.

Report from the 27th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Calgary, Alberta, 26-27 September 2025: Advances in Colon and Rectal Cancer.

Journal: Current oncology (Toronto, Ont.)

Published: June 01, 2026

Tailored management of a melanoma patient with bleeding brain metastases and deep vein thrombosis with thrombectomy.

Tailored management of a melanoma patient with bleeding brain metastases and deep vein thrombosis with thrombectomy.

Journal: CNS oncology

Published: May 20, 2026

Treatment Selection Beyond Second Line in Metastatic Colorectal Cancer: Practical Sequencing of Cytotoxic Salvage Therapy, Anti-angiogenic Agents, Rechallenge Strategies, and Biomarker-Guided Treatments.

Treatment Selection Beyond Second Line in Metastatic Colorectal Cancer: Practical Sequencing of Cytotoxic Salvage Therapy, Anti-angiogenic Agents, Rechallenge Strategies, and Biomarker-Guided Treatments.

Journal: Journal of gastrointestinal cancer

Published: May 06, 2026

primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma.

primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 16, 2026

BRAF V600E-Mutated Metastatic Colorectal Cancer: Practical Management in the Post-BREAKWATER Era.

BRAF V600E-Mutated Metastatic Colorectal Cancer: Practical Management in the Post-BREAKWATER Era.

Journal: Journal of gastrointestinal cancer

Published: April 13, 2026

Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma.

Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma.

Journal: Future oncology (London, England)

Published: March 31, 2026

A plain language summary of the updated results from the PHAROS study: the combination of encorafenib plus binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer.

A plain language summary of the updated results from the PHAROS study: the combination of encorafenib plus binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer.

Journal: Future oncology (London, England)

Published: March 30, 2026

Recent progress in clinical and molecular biological research in rectal serrated lesions.

Recent progress in clinical and molecular biological research in rectal serrated lesions.

Journal: Molecular biology reports

Published: March 28, 2026

Showing 1-12 of 512

Last Updated: 09/26/2026